Advertisement
LTRN vs TBPH
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LTRN is a Hold and TBPH is a Hold.
LTRN's Indicator enters downward trend
The Aroon Indicator for LTRN entered a downward trend on October 20, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 274 similar instances where the Aroon Indicator formed such a pattern. In 248 of the 274 cases the stock moved lower. This puts the odds of a downward move at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LTRN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Moving Average Convergence Divergence (MACD) for LTRN just turned positive on October 13, 2026. Looking at past instances where LTRN's MACD turned positive, the stock continued to rise in 43 of 51 cases over the following month. The odds of a continued upward trend are 84%.
Following a +10.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where LTRN advanced for three days, in 199 of 247 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
LTRN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-2.608) is normal, around the industry mean (3.009). P/E Ratio (-0.403) is within average values for comparable stocks, (-1.027). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (129.622) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron Seasonality Score of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. LTRN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LTRN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Momentum Indicator for TBPH turns positive, indicating new upward trend
TBPH saw its Momentum Indicator move above the 0 level on October 06, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 97 similar instances where the indicator turned positive. In 76 of the 97 cases, the stock moved higher in the following days. The odds of a move higher are at 78%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Aroon Indicator entered an Uptrend today. In 96 of 152 cases where TBPH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 63%.
Bearish Trend Analysis
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 34 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 43 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. TBPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.052) is normal, around the industry mean (3.009). P/E Ratio (16.066) is within average values for comparable stocks, (-1.027). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (129.622) among similar stocks. P/S Ratio (8.475) is also within normal values, averaging (438.009).
The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
LTRN | TBPH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 57 | 48 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 23 Undervalued | 85 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 34 | |
SMR RATING 1..100 | 100 | 43 | |
PRICE GROWTH RATING 1..100 | 97 | 47 | |
P/E GROWTH RATING 1..100 | 6 | 95 | |
SEASONALITY SCORE 1..100 | 49 | 33 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
LTRN's Valuation (23) in the null industry is somewhat better than the same rating for TBPH (85) in the Pharmaceuticals Other industry. This means that LTRN’s stock grew somewhat faster than TBPH’s over the last 12 months.
TBPH's Profit vs Risk Rating (34) in the Pharmaceuticals Other industry is significantly better than the same rating for LTRN (100) in the null industry. This means that TBPH’s stock grew significantly faster than LTRN’s over the last 12 months.
TBPH's SMR Rating (43) in the Pharmaceuticals Other industry is somewhat better than the same rating for LTRN (100) in the null industry. This means that TBPH’s stock grew somewhat faster than LTRN’s over the last 12 months.
TBPH's Price Growth Rating (47) in the Pharmaceuticals Other industry is somewhat better than the same rating for LTRN (97) in the null industry. This means that TBPH’s stock grew somewhat faster than LTRN’s over the last 12 months.
LTRN's P/E Growth Rating (6) in the null industry is significantly better than the same rating for TBPH (95) in the Pharmaceuticals Other industry. This means that LTRN’s stock grew significantly faster than TBPH’s over the last 12 months.
| LTRN | TBPH | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 69% | N/A |
| Stochastic ODDS (%) | N/A | 1 day ago 78% |
| Momentum ODDS (%) | N/A | 1 day ago 78% |
| MACD ODDS (%) | 1 day ago 84% | N/A |
| TrendWeek ODDS (%) | 1 day ago 86% | 1 day ago 70% |
| TrendMonth ODDS (%) | 1 day ago 89% | 1 day ago 72% |
| Advances ODDS (%) | 15 days ago 81% | N/A |
| Declines ODDS (%) | 6 days ago 86% | N/A |
| BollingerBands ODDS (%) | 1 day ago 73% | N/A |
| Aroon ODDS (%) | 1 day ago 90% | 5 days ago 63% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
LTRN’s FA Score shows that 2 FA rating(s) are green while TBPH’s FA Score has 0 green FA rating(s).
- LTRN’s FA Score: 2 green, 3 red.
- TBPH’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
LTRN’s TA Score shows that 4 TA indicator(s) are bullish while TBPH’s TA Score has 3 bullish TA indicator(s).
- LTRN’s TA Score: 4 bullish, 2 bearish.
- TBPH’s TA Score: 3 bullish, 0 bearish.
Price Growth
LTRN (@Biotechnology) experienced а -7.64% price change this week, while TBPH (@Biotechnology) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -0.45%. For the same industry, the average monthly price growth was -16.03%, and the average quarterly price growth was -14.84%.
Reported Earning Dates
LTRN is expected to report earnings on Nov 11, 2026.
TBPH is expected to report earnings on Nov 10, 2026.
Industries' Descriptions
@Biotechnology (-0.45% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
LTRN and
Correlation & Price change
A.I.dvisor indicates that over the last year, LTRN has been loosely correlated with ALZN. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if LTRN jumps, then ALZN could also see price increases.
| Ticker / NAME | Correlation To LTRN | 1D Price Change % | ||
|---|---|---|---|---|
| LTRN | 100% | +2.35% | ||
| ALZN - LTRN | 39% Loosely correlated | -3.01% | ||
| AXON - LTRN | 36% Loosely correlated | +2.49% | ||
| CGTX - LTRN | 34% Loosely correlated | +0.88% | ||
| RCKT - LTRN | 32% Poorly correlated | +4.46% | ||
| CCCC - LTRN | 31% Poorly correlated | +9.34% | ||
More | ||||
TBPH and
Correlation & Price change
A.I.dvisor indicates that over the last year, TBPH has been loosely correlated with ALDX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if TBPH jumps, then ALDX could also see price increases.
| Ticker / NAME | Correlation To TBPH | 1D Price Change % | ||
|---|---|---|---|---|
| TBPH | 100% | N/A | ||
| ALDX - TBPH | 50% Loosely correlated | +10.40% | ||
| CLDI - TBPH | 46% Loosely correlated | -1.71% | ||
| MAZE - TBPH | 44% Loosely correlated | +9.26% | ||
| LTRN - TBPH | 41% Loosely correlated | +2.35% | ||
| VALN - TBPH | 40% Loosely correlated | +3.27% | ||
More | ||||